PATH VACCINE SOLUTIONS: Form 990, tax year 2011

View the entire original 990 at ProPublica ↗

Organization
PATH VACCINE SOLUTIONS (EIN 83-0431851)
Tax period
2011-01-01 to 2011-12-31
Filed
2012-11-13
IRS object ID
201233189349302903
Schema version
2011v1.2
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Timestamp2012-11-13T12:58:33-06:00Timestamp
Tax Period End Date2011-12-31TaxPeriodEndDate

Preparer Firm PreparerFirm

FieldValueIRS element (for citing)
EIN521392008EIN

Preparer Firm Business Name PreparerFirmBusinessName

FieldValueIRS element (for citing)
Business Name Line1GELMAN ROSENBERG & FREEDMANBusinessNameLine1

Preparer Firm US Address PreparerFirmUSAddress

FieldValueIRS element (for citing)
Address Line14550 MONTGOMERY AVE SUITE 650NAddressLine1
CityBETHESDACity
StateMDState
ZIP Code208142930ZIPCode
FieldValueIRS element (for citing)
Return Type990ReturnType
Tax Period Begin Date2011-01-01TaxPeriodBeginDate

Filer Filer

FieldValueIRS element (for citing)
EIN830431851EIN

Name Name

FieldValueIRS element (for citing)
Business Name Line1PATH VACCINE SOLUTIONSBusinessNameLine1
FieldValueIRS element (for citing)
Name ControlPATHNameControl
Phone2062853500Phone

US Address USAddress

FieldValueIRS element (for citing)
Address Line12201 WESTLAKE AVENUE NO 200AddressLine1
CitySEATTLECity
StateWAState
ZIP Code98121ZIPCode

Officer Officer

FieldValueIRS element (for citing)
NameMARLOW KEEName
TitleCFO & TREASURERTitle
Phone2062853500Phone
Date Signed2012-11-13DateSigned
Authorize Third Party1AuthorizeThirdParty

Preparer Preparer

FieldValueIRS element (for citing)
Phone3019519090Phone
FieldValueIRS element (for citing)
Tax Year2011TaxYear
Build TS2016-02-24 21:20:13ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Name Of Principal Officer PersonMARLOW KEENameOfPrincipalOfficerPerson

Address Principal Officer US AddressPrincipalOfficerUS

FieldValueIRS element (for citing)
Address Line12201 WESTLAKE AVENUE NO 200AddressLine1
CitySEATTLECity
StateWAState
ZIP Code98121ZIPCode
FieldValueIRS element (for citing)
Gross Receipts42220153GrossReceipts
Group Return For Affiliates0GroupReturnForAffiliates
Organization501c3XOrganization501c3
Web SiteWWW.PATH.ORGWebSite
Type Of Organization CorporationXTypeOfOrganizationCorporation
Year Formation2006YearFormation
State Legal DomicileWAStateLegalDomicile
Activity Or Mission DescriptionTHE MISSION OF PATH VACCINE SOLUTIONS (PVS) IS TO IMPROVE THE HEALTH OF CHILDREN IN LOW-INCOME COUNTRIES BY ACCELERATING THE DEVELOPMENT OF VACCINES THAT WILL BE EFFECTIVE AND AFFORDABLE IN COUNTRIES THAT NEED THEM MOST. FROM INITIAL DISCOVERY THROUGH CLINICAL TRIALS, PVS WORKS WITH COMMERCIAL PARTNERS, SUCH AS VACCINE MANUFACTURERS AND BIOTECHNOLOGY FIRMS, AND NONPROFIT PARTNERS, SUCH AS UNIVERSITIES AND RESEARCH INSTITUTIONS, TO SHORTEN THE TIMELINE FOR VACCINE DEVELOPMENT.ActivityOrMissionDescription
Nbr Voting Members Governing Body7NbrVotingMembersGoverningBody
Nbr Independent Voting Members3NbrIndependentVotingMembers
Total Nbr Employees0TotalNbrEmployees
Total Nbr Volunteers0TotalNbrVolunteers
Total Gross UBI0TotalGrossUBI
Net Unrelated Business Txbl Income0NetUnrelatedBusinessTxblIncome
Contributions Grants Prior Year32724826ContributionsGrantsPriorYear
Contributions Grants Current Year17377524ContributionsGrantsCurrentYear
Program Service Revenue Prior Year3500ProgramServiceRevenuePriorYear
Program Service Revenue CY0ProgramServiceRevenueCY
Investment Income Prior Year53857InvestmentIncomePriorYear
Investment Income Current Year805398InvestmentIncomeCurrentYear
Other Revenue Prior Year7148OtherRevenuePriorYear
Other Revenue Current Year-1385OtherRevenueCurrentYear
Total Revenue Prior Year32789331TotalRevenuePriorYear
Total Revenue Current Year18181537TotalRevenueCurrentYear
Grants And Similar Amnts Prior Year30660682GrantsAndSimilarAmntsPriorYear
Grants And Similar Amnts CY30822158GrantsAndSimilarAmntsCY
Benefits Paid To Members Prior Year0BenefitsPaidToMembersPriorYear
Benefits Paid To Members CY0BenefitsPaidToMembersCY
Salaries Etc Prior Year0SalariesEtcPriorYear
Salaries Etc Current Year0SalariesEtcCurrentYear
Total Prof Fundrsng Exp Prior Year0TotalProfFundrsngExpPriorYear
Total Prof Fundrsng Exp CY0TotalProfFundrsngExpCY
Total Fundrsng Exp Current Year0TotalFundrsngExpCurrentYear
Other Expense Prior Year5260313OtherExpensePriorYear
Other Expenses Current Year6404407OtherExpensesCurrentYear
Total Expenses Prior Year35920995TotalExpensesPriorYear
Total Expenses Current Year37226565TotalExpensesCurrentYear
Revenues Less Expenses Prior Year-3131664RevenuesLessExpensesPriorYear
Revenues Less Expenses CY-19045028RevenuesLessExpensesCY
Total Assets BOY151102797TotalAssetsBOY
Total Assets EOY133507981TotalAssetsEOY
Total Liabilities BOY4781234TotalLiabilitiesBOY
Total Liabilities EOY6691219TotalLiabilitiesEOY
Net Assets Or Fund Balances BOY146321563NetAssetsOrFundBalancesBOY
Net Assets Or Fund Balances EOY126816762NetAssetsOrFundBalancesEOY
Info In Schedule O Part IIIXInfoInScheduleOPartIII
Mission DescriptionPVS WORKS WITH PARTNERS TO DEVELOP NEW VACCINES BY PROVIDING FUNDING AND EXPERTISE IN NONCLINICAL DEVELOPMENT, MANUFACTURING, AND CLINICAL DEVELOPMENT, WITH A FOCUS ON LOW-INCOME COUNTRIES. IN RETURN, PARTNERS AGREE TO TERMS THAT WILL HELP ENSURE THAT THE PRODUCTS ARE AFFORDABLE AND AVAILABLE IN DEVELOPING COUNTRIES.MissionDescription
Significant New Program Services0SignificantNewProgramServices
Significant Change0SignificantChange
Expense37226565Expense
Grants30822158Grants
DescriptionPVS WORKS TO PREVENT DEATHS FROM PNEUMONIA, INFLUENZA, RESPIRATORY SYNCYTIAL VIRUS, POLIO, AND DIARRHEA AMONG CHILDREN AROUND THE WORLD. WE ACCELERATE THE DEVELOPMENT OF SAFE, EFFICACIOUS, AND AFFORDABLE VACCINES IN PARTNERSHIP WITH PUBLIC AND PRIVATE GROUPS. IN 2011 PVS ADVANCED RESEARCH AND DEVELOPMENT OF A NUMBER OF PROMISING PNEUMOCOCCAL VACCINE CANDIDATES AND RELATED TECHNOLOGIES. THIS WORK RANGED FROM PRELIMINARY RESEARCH TO PRECLINICAL DEVELOPMENT TO CLINICAL TRIALS FOR SEVERAL CANDIDATES. FOR EXAMPLE, WE MADE PREPARATIONS TO ADVANCE AN INACTIVATED WHOLE-CELL VACCINE INTO PHASE 1 CLINICAL TRIALS, AND WE LAUNCHED A TWO-STAGE PHASE 2 CLINICAL TRIAL IN THE GAMBIA OF A VACCINE AGAINST STREPTOCOCCUS PNEUMONIAE. OUR PARTNERS INCLUDED ACADEMIC GROUPS (SUCH AS THE UNIVERSITY OF ADELAIDE, THE UNIVERSITY OF OKLAHOMA, AND THE LONDON SCHOOL OF HYGIENE & TROPICAL MEDICINE), INDUSTRY PARTNERS (INCLUDING GENOCEA BIOSCIENCES, GLAXOSMITHKLINE BIOLOGICALS, LIQUIDIA TECHNOLOGIES, MUCOSIS BV, AND THE SERUM INSTITUTE OF INDIA LTD.), AND HEALTH CARE INSTITUTIONS (SUCH AS BOSTON CHILDREN'S HOSPITAL AND ST. JUDE CHILDREN'S RESEARCH HOSPITAL). DURING 2011 PVS ALSO ADVANCED THE DEVELOPMENT OF PROMISING NEW INFLUENZA VACCINES, FOCUSING ON NOVEL TECHNOLOGIES THAT CAN BE ACCESSIBLE, AFFORDABLE, AND AVAILABLE TO PEOPLE IN LOW-RESOURCE SETTINGS DURING INFLUENZA OUTBREAKS. HIGHLIGHTS INCLUDED COMPLETING PRECLINICAL DEVELOPMENT OF SEVERAL AVIAN LIVE ATTENUATED INFLUENZA VACCINE CANDIDATES, PREPARING FOR TESTING A SEASONAL INFLUENZA VACCINE AMONG CHILDREN IN BANGLADESH, LAUNCHING A CLINICAL STUDY TO DETERMINE THE IMMUNOLOGIC POTENTIAL OF AVIAN LIVE ATTENUATED INFLUENZA VACCINE TO BOOST THE RESPONSE OF INACTIVATED INFLUENZA VACCINES, AND INITIATING A NEW RESPIRATORY SYNCYTIAL VIRUS VACCINE COMPONENT OF OUR INFLUENZA PORTFOLIO. OUR PARTNERS INCLUDED THE INSTITUTE OF EXPERIMENTAL MEDICINE IN RUSSIA, MEDICAGO INC., LENTIGEN, THE UNIVERSITY OF PITTSBURGH, AND THE INFECTIOUS DISEASE RESEARCH INSTITUTE OF SEATTLE.INFECTION WITH ROTAVIRUS IS A MAJOR CAUSE OF SEVERE DIARRHEA AND DEATH AMONG YOUNG CHILDREN IN LOW-INCOME COUNTRIES. PVS AIMS TO ACCELERATE INTRODUCTION OF SAFE, AFFORDABLE, AND EFFECTIVE ROTAVIRUS VACCINES BY PROVIDING TECHNICAL AND FINANCIAL SUPPORT TO EMERGING-COUNTRY MANUFACTURERS. HIGHLIGHTS DURING 2011 INCLUDED WORKING WITH BHARAT BIOTECH INTERNATIONAL LTD. IN INDIA TO SUPPORT THE LAUNCH OF A PHASE 3 EFFICACY TRIAL OF ITS PROMISING VACCINE CANDIDATE; PARTNERING WITH THE SERUM INSTITUTE OF INDIA LTD. TO PREPARE FOR PHASE 3 CLINICAL TRIALS OF ANOTHER TYPE OF ROTAVIRUS VACCINE; AND PROVIDING A SHARED TECHNOLOGY PLATFORM THAT ALLOWS MANUFACTURERS OF NEW ROTAVIRUS VACCINES TO ACCESS A HOST OF NEEDED TECHNOLOGIES, TRAINING, AND TECHNICAL SUPPORT.PVS ALSO ADVANCES RESEARCH AND DEVELOPMENT OF VACCINES AGAINST THE TWO LEADING BACTERIAL CAUSES OF DIARRHEA, SHIGELLA AND ENTEROTOXIGENIC ESCHERICHIA COLI. MUCH OF THIS WORK IS DONE THROUGH PARTNERSHIPS WITH PUBLIC- AND PRIVATE-SECTOR ORGANIZATIONS. KEY ACTIVITIES IN 2011 INCLUDED SIGNING SEVEN NEW PARTNERSHIP AGREEMENTS FOR RESEARCH, DEVELOPMENT, AND TESTING OF VACCINE CANDIDATES AND RELATED TECHNOLOGY; COMPLETING A PHASE 2B CHALLENGE STUDY OF ONE VACCINE CANDIDATE AND HELPING TO SUPPORT THE LAUNCH OF PHASE 1 TRIALS OF TWO OTHER VACCINE CANDIDATES; AND FUNDING AND HOSTING WORKSHOPS IN VIETNAM ON DIARRHEAL DISEASE AND THE USE OF ORAL VACCINES IN INFANTS. OUR PARTNERS INCLUDED THE INTERNATIONAL VACCINE INITIATIVE, OKLAHOMA STATE UNIVERSITY, THE US NAVAL MEDICAL RESEARCH CENTER, MUCOSIS BV, THE UNIVERSITY OF MARYLAND, BALTIMORE, AND THE WALTER REED ARMY INSTITUTE OF RESEARCH. IN 2011, PVS ADDED NEW PROJECTS TO WORK ON VACCINES AGAINST POLIO AND RESPIRATORY SYNCYTIAL VIRUS.Description
Total Program Service Expense37226565TotalProgramServiceExpense
Described In501 C31DescribedIn501C3
Schedule B Required1ScheduleBRequired
Political Activities0PoliticalActivities
Lobbying Activities0LobbyingActivities
Subject To Proxy Tax0SubjectToProxyTax
Donor Advised Funds0DonorAdvisedFunds
Conservation Easements0ConservationEasements
Collections Of Art0CollectionsOfArt
Credit Counseling0CreditCounseling
Term Or Permanent Endowments0TermOrPermanentEndowments
Report Land Bldg Equip0ReportLandBldgEquip
Report Invest Oth Securities0ReportInvestOthSecurities
Report Prog Rel Invest0ReportProgRelInvest
Report Other Assets0ReportOtherAssets
Report Other Liabilities0ReportOtherLiabilities
Report Fin48 Footnote0ReportFin48Footnote
Independent Audit Financial Stmt0IndependentAuditFinancialStmt
Consolidated Audit Financial Stmt1ConsolidatedAuditFinancialStmt
School0School
Foreign Office1ForeignOffice
Foreign Activities1ForeignActivities
More Than5000 K To Organizations1MoreThan5000KToOrganizations
More Than5000 K To Individuals0MoreThan5000KToIndividuals
Professional Fundraising0ProfessionalFundraising
Fundraising Activities0FundraisingActivities
Gaming0Gaming
Hospital0Hospital
Grants To Organizations1GrantsToOrganizations
Grants To Individuals0GrantsToIndividuals
Schedule J Required1ScheduleJRequired
Tax Exempt Bonds0TaxExemptBonds
Excess Benefit Transaction0ExcessBenefitTransaction
Prior Excess Benefit Transaction0PriorExcessBenefitTransaction
Loan To Officer Or DQP0LoanToOfficerOrDQP
Grant To Related Person0GrantToRelatedPerson
Bsnss Rltnshp With Organization0BsnssRltnshpWithOrganization
Bsnss Rltnshp Thru Family Member0BsnssRltnshpThruFamilyMember
Officer Entity With Bsnss Rltnshp0OfficerEntityWithBsnssRltnshp
Deductible Non Cash Contributions0DeductibleNonCashContributions
Deductible Contributions Of Art0DeductibleContributionsOfArt
Terminated0Terminated
Partial Liquidation0PartialLiquidation
Disregarded Entity0DisregardedEntity
Related Entity1RelatedEntity
Related Org Controlled Entity0RelatedOrgControlledEntity
Transaction Related Entity0TransactionRelatedEntity
Transfers To Exempt Non Chrtbl Org0TransfersToExemptNonChrtblOrg
Activities Conducted Partnership0ActivitiesConductedPartnership
Schedule O Required1ScheduleORequired
Number Forms Transmitted With10960NumberFormsTransmittedWith1096
Number W2 G Included0NumberW2GIncluded
Number Of Employees0NumberOfEmployees
Unrelated Business Income0UnrelatedBusinessIncome
Foreign Financial Account0ForeignFinancialAccount
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTrans
Taxable Party Notification0TaxablePartyNotification
Non Deductible Contributions0NonDeductibleContributions
Quid Pro Quo Contributions0QuidProQuoContributions
Form8282 Property Disposed Of0Form8282PropertyDisposedOf
Funds To Pay Premiums0FundsToPayPremiums
Premiums Paid0PremiumsPaid
Indoor Tanning Services0IndoorTanningServices
Info In Schedule O Part VIXInfoInScheduleOPartVI
Nbr Voting Governing Body Members7NbrVotingGoverningBodyMembers
Number Independent Voting Members3NumberIndependentVotingMembers
Family Or Business Relationship0FamilyOrBusinessRelationship
Delegation Of Management Duties0DelegationOfManagementDuties
Changes To Organizing Docs0ChangesToOrganizingDocs
Material Diversion Or Misuse0MaterialDiversionOrMisuse
Members Or Stockholders0MembersOrStockholders
Election Of Board Members0ElectionOfBoardMembers
Decisions Subject To Approval0DecisionsSubjectToApproval
Minutes Of Governing Body1MinutesOfGoverningBody
Minutes Of Committees1MinutesOfCommittees
Officer Mailing Address0OfficerMailingAddress
Local Chapters0LocalChapters
Form990 Provided To Governing Body1Form990ProvidedToGoverningBody
Conflict Of Interest Policy1ConflictOfInterestPolicy
Annual Disclosure Covered Persons1AnnualDisclosureCoveredPersons
Regular Monitoring Enforcement1RegularMonitoringEnforcement
Whistleblower Policy1WhistleblowerPolicy
Document Retention Policy1DocumentRetentionPolicy
Compensation Process CEO0CompensationProcessCEO
Compensation Process Other0CompensationProcessOther
Investment In Joint Venture0InvestmentInJointVenture
States Where Copy Of Return Is FiledWAStatesWhereCopyOfReturnIsFiled
Other WebsiteXOtherWebsite
Upon RequestXUponRequest

The Books Are In Care Of TheBooksAreInCareOf

Name Business NameBusiness

FieldValueIRS element (for citing)
Business Name Line1MARLOW KEE CHIEF FINANCIAL OFFICERBusinessNameLine1
FieldValueIRS element (for citing)
Telephone Number2062853500TelephoneNumber

Address US AddressUS

FieldValueIRS element (for citing)
Address Line12201 WESTLAKE AVE SUITE 200AddressLine1
CitySEATTLECity
StateWAState
ZIP Code98121ZIPCode

Form990 Part VII Section A Form990PartVIISectionA (8 entries)

TitleTitleAverage Hours Per WeekAverageHoursPerWeekIndividual Trustee Or DirectorIndividualTrusteeOrDirectorOfficerOfficerReportable Comp From OrganizationReportableCompFromOrganizationReportable Comp From Related OrgsReportableCompFromRelatedOrgsOther CompensationOtherCompensation
CHRISTOPHER J ELIAS
CHAIR1.00XX052444539496
JACQUELINE D SHERRIS
VICE CHAIR1.00XX024432419102
ERIC G WALKER
TREASURER1.00XX023533635164
DAN LASTER
DIRECTOR/GENERAL COUNSEL1.00X021692727234
N REGINA RABINOVICH
DIRECTOR1.00X000
DOUGLAS HOLTZMAN
DIRECTOR1.00X000
TOM BREWER
DIRECTOR1.00X000
DAVID ALLI
BOARD SECRETARY1.00X014314725761
FieldValueIRS element (for citing)
Total Reportable Comp From Org0TotalReportableCompFromOrg
Total Reportable Comp Frm Rltd Orgs1364179TotalReportableCompFrmRltdOrgs
Total Other Compensation146757TotalOtherCompensation
Number Individuals GT100 K0NumberIndividualsGT100K
Formers Listed0FormersListed
Total Comp GT150 K1TotalCompGT150K
Compensation From Other Sources0CompensationFromOtherSources
Number Of Contractors GT100 K0NumberOfContractorsGT100K
All Other Contributions17377524AllOtherContributions
Total Contributions17377524TotalContributions

Investment Income InvestmentIncome

FieldValueIRS element (for citing)
Total Revenue Column754517TotalRevenueColumn
Exclusion$754,517ExclusionAmount

Gross Amount Sales Assets GrossAmountSalesAssets

FieldValueIRS element (for citing)
Securities24089497Securities

Less Cost Oth Basis Sales Expenses LessCostOthBasisSalesExpenses

FieldValueIRS element (for citing)
Securities24038616Securities

Gain Or Loss GainOrLoss

FieldValueIRS element (for citing)
Securities50881Securities

Net Gain Or Loss Investments NetGainOrLossInvestments

FieldValueIRS element (for citing)
Total Revenue Column50881TotalRevenueColumn
Exclusion$50,881ExclusionAmount

Other Revenue Misc OtherRevenueMisc

FieldValueIRS element (for citing)
DescriptionOTHER REIMBURSEMENTDescription
Business Code900099BusinessCode
Total Revenue Column-1385TotalRevenueColumn
Exclusion-$1,385ExclusionAmount
FieldValueIRS element (for citing)
Total Other Revenue-1385TotalOtherRevenue

Total Revenue TotalRevenue

FieldValueIRS element (for citing)
Total Revenue Column18181537TotalRevenueColumn
Related Or Exempt Function Income0RelatedOrExemptFunctionIncome
Unrelated Business Revenue0UnrelatedBusinessRevenue
Exclusion$804,013ExclusionAmount

Grants To Domestic Orgs GrantsToDomesticOrgs

FieldValueIRS element (for citing)
Total19277039Total
Program Services19277039ProgramServices

Foreign Grants ForeignGrants

FieldValueIRS element (for citing)
Total11545119Total
Program Services11545119ProgramServices

Fees For Services Legal FeesForServicesLegal

FieldValueIRS element (for citing)
Total79876Total
Program Services79876ProgramServices

Fees For Services Accounting FeesForServicesAccounting

FieldValueIRS element (for citing)
Total2883Total
Program Services2883ProgramServices

Fees For Services Invst Mgmnt Fees FeesForServicesInvstMgmntFees

FieldValueIRS element (for citing)
Total112832Total
Program Services112832ProgramServices

Fees For Services Other FeesForServicesOther

FieldValueIRS element (for citing)
Total653828Total
Program Services653828ProgramServices

Advertising Advertising

FieldValueIRS element (for citing)
Total888Total
Program Services888ProgramServices

Office Expenses OfficeExpenses

FieldValueIRS element (for citing)
Total277001Total
Program Services277001ProgramServices

Information Technology InformationTechnology

FieldValueIRS element (for citing)
Total5717Total
Program Services5717ProgramServices

Royalties Royalties

FieldValueIRS element (for citing)
Total32500Total
Program Services32500ProgramServices

Occupancy Occupancy

FieldValueIRS element (for citing)
Total2296Total
Program Services2296ProgramServices

Travel Travel

FieldValueIRS element (for citing)
Total1622613Total
Program Services1622613ProgramServices

Conferences Meetings ConferencesMeetings

FieldValueIRS element (for citing)
Total124793Total
Program Services124793ProgramServices

Insurance Insurance

FieldValueIRS element (for citing)
Total164384Total
Program Services164384ProgramServices

Other Expenses OtherExpenses (4 entries)

DescriptionDescriptionTotalTotalProgram ServicesProgramServices
SUBCONTRACTS31134993113499
LAB SUPPLIES111374111374
TAXES6431264312
EQUIPMENT R&M & PROCURE99919991

All Other Expenses AllOtherExpenses

FieldValueIRS element (for citing)
Total25620Total
Program Services25620ProgramServices

Total Functional Expenses TotalFunctionalExpenses

FieldValueIRS element (for citing)
Total37226565Total
Program Services37226565ProgramServices
Management And General0ManagementAndGeneral
Fundraising0Fundraising

Savings And Temp Cash Investments SavingsAndTempCashInvestments

FieldValueIRS element (for citing)
BOY10065380BOY
EOY6827477EOY

Pledges And Grants Receivable PledgesAndGrantsReceivable

FieldValueIRS element (for citing)
BOY80022019BOY
EOY58943532EOY

Accounts Receivable AccountsReceivable

FieldValueIRS element (for citing)
BOY78013BOY
EOY267335EOY

Prepaid Expenses Deferred Charges PrepaidExpensesDeferredCharges

FieldValueIRS element (for citing)
EOY165118EOY

Investments Pub Traded Securities InvestmentsPubTradedSecurities

FieldValueIRS element (for citing)
BOY60937385BOY
EOY67304519EOY

Total Assets TotalAssets

FieldValueIRS element (for citing)
BOY151102797BOY
EOY133507981EOY

Accounts Payable Accrued Expenses AccountsPayableAccruedExpenses

FieldValueIRS element (for citing)
BOY4781234BOY
EOY6691219EOY

Total Liabilities TotalLiabilities

FieldValueIRS element (for citing)
BOY4781234BOY
EOY6691219EOY
FieldValueIRS element (for citing)
Follow SFAS117XFollowSFAS117

Temporarily Restricted Net Assets TemporarilyRestrictedNetAssets

FieldValueIRS element (for citing)
BOY146321563BOY
EOY126816762EOY

Total Net Assets Fund Balances TotalNetAssetsFundBalances

FieldValueIRS element (for citing)
BOY146321563BOY
EOY126816762EOY

Total Liab Net Assets Fund Balances TotalLiabNetAssetsFundBalances

FieldValueIRS element (for citing)
BOY151102797BOY
EOY133507981EOY
FieldValueIRS element (for citing)
Info In Schedule O Part XIXInfoInScheduleOPartXI
Reconcilation Revenue Expenses-19045028ReconcilationRevenueExpenses
Reconcilation Other Changes-459773ReconcilationOtherChanges
Method Of Accounting AccrualXMethodOfAccountingAccrual
Accountant Compile Or Review0AccountantCompileOrReview
FS Audited1FSAudited
Audit Committee1AuditCommittee
Financial Statement ConsolidatedXFinancialStatementConsolidated
Federal Grant Audit Required0FederalGrantAuditRequired

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Supporting Organization509a3XSupportingOrganization509a3
Supporting Org509a3 Type1XSupportingOrg509a3Type1
Certification CheckboxXCertificationCheckbox
Contrib By Controlling Individual0ContribByControllingIndividual
Contribution By Related Party0ContributionByRelatedParty
Contrib By35 Controlled Entity0ContribBy35ControlledEntity

Supported Org Information SupportedOrgInformation

Name Name

FieldValueIRS element (for citing)
Business Name Line1PATHBusinessNameLine1
FieldValueIRS element (for citing)
EIN911157127EIN
Type Of OrganizationBOX 7TypeOfOrganization
Listed In Governing Doc1ListedInGoverningDoc
Amount$37,226,565Amount
FieldValueIRS element (for citing)
Total Number Of Supported Orgs1TotalNumberOfSupportedOrgs
Sum Of Amounts37226565SumOfAmounts

Schedule B IRS990ScheduleB

Contributor Info ContributorInfo

FieldValueIRS element (for citing)
Contributor NumberRESTRICTEDContributorNumber

Contributor Name Business ContributorNameBusiness

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor Address US ContributorAddressUS

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Aggregate ContributionsRESTRICTEDAggregateContributions

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records Maintained1GrantRecordsMaintained

Accts Actvs Out US Table AcctsActvsOutUSTable (14 entries)

RegionRegionNumber Of OfficesNumberOfOfficesNumber Of EmployeesNumberOfEmployeesType Of Activities ConductedTypeOfActivitiesConductedSpecific Services ProvidedSpecificServicesProvidedTotal ExpendituresTotalExpenditures
EAST ASIA AND THE PACIFIC00PROGRAM SERVICESVACCINES AND IMMUNIZATIONS240382
EAST ASIA AND THE PACIFIC00GRANTS3850973
EUROPE04PROGRAM SERVICESVACCINES AND IMMUNIZATIONS1335193
EUROPE00GRANTS2141935
MIDDLE EAST00PROGRAM SERVICESVACCINES AND IMMUNIZATIONS520
NORTH AMERICA00PROGRAM SERVICESVACCINES AND IMMUNIZATIONS25128
NORTH AMERICA00GRANTS575000
RUSSIA AND THE NEWLY INDEPENDENT STATES00PROGRAM SERVICESVACCINES AND IMMUNIZATIONS61880
RUSSIA AND THE NEWLY INDEPENDENT STATES00GRANTS961913
SOUTH AMERICA00PROGRAM SERVICESVACCINES AND IMMUNIZATIONS15
SOUTH ASIA08PROGRAM SERVICESVACCINES AND IMMUNIZATIONS656197
SOUTH ASIA00GRANTS1759246
SUB-SAHARAN AFRICA00PROGRAM SERVICESVACCINES AND IMMUNIZATIONS103756
SUB-SAHARAN AFRICA00GRANTS2256051
FieldValueIRS element (for citing)
Subtotal Number Of Offices0SubtotalNumberOfOffices
Subtotal Number Of Employees4SubtotalNumberOfEmployees
Cont Number Of Offices0ContNumberOfOffices
Cont Number Of Employees8ContNumberOfEmployees
Total Number Of Offices0TotalNumberOfOffices
Total Number Of Employees12TotalNumberOfEmployees
Subtotal Amount Spent8231011SubtotalAmountSpent
Cont Amount Spent5737178ContAmountSpent
Total Amount Spent13968189TotalAmountSpent

Grants To Orgs Outside US GrantsToOrgsOutsideUS (35 entries)

RegionRegionPurpose Of GrantPurposeOfGrantAmount Of Cash GrantAmountOfCashGrantManner Of Cash DisbursementMannerOfCashDisbursement
EAST ASIAVACCINES AND IMMUNIZATIONS50143CHECK / WIRE
EAST ASIAVACCINES AND IMMUNIZATIONS6879CHECK / WIRE
EAST ASIAVACCINES AND IMMUNIZATIONS600000CHECK / WIRE
EAST ASIAVACCINES AND IMMUNIZATIONS60000CHECK / WIRE
EAST ASIAVACCINES AND IMMUNIZATIONS900000CHECK / WIRE
EAST ASIAVACCINES AND IMMUNIZATIONS610000CHECK / WIRE
EAST ASIAVACCINES AND IMMUNIZATIONS13266CHECK / WIRE
EAST ASIAVACCINES AND IMMUNIZATIONS19165CHECK / WIRE
EAST ASIAVACCINES AND IMMUNIZATIONS6554CHECK / WIRE
EAST ASIAVACCINES AND IMMUNIZATIONS1584965CHECK / WIRE
EUROPEVACCINES AND IMMUNIZATIONS56349CHECK / WIRE
EUROPEVACCINES AND IMMUNIZATIONS186711CHECK / WIRE
EUROPEVACCINES AND IMMUNIZATIONS34507CHECK / WIRE
EUROPEVACCINES AND IMMUNIZATIONS30387CHECK / WIRE
EUROPEVACCINES AND IMMUNIZATIONS1147000CHECK / WIRE
EUROPEVACCINES AND IMMUNIZATIONS211054CHECK / WIRE
EUROPEVACCINES AND IMMUNIZATIONS35368CHECK / WIRE
EUROPEVACCINES AND IMMUNIZATIONS289168CHECK / WIRE
EUROPEVACCINES AND IMMUNIZATIONS150000CHECK / WIRE
NORTH AMERICAVACCINES AND IMMUNIZATIONS500000CHECK / WIRE
NORTH AMERICAVACCINES AND IMMUNIZATIONS75000CHECK / WIRE
RUSSIAVACCINES AND IMMUNIZATIONS961914CHECK / WIRE
SOUTH ASIAVACCINES AND IMMUNIZATIONS42966CHECK / WIRE
SOUTH ASIAVACCINES AND IMMUNIZATIONS83227CHECK / WIRE
SOUTH ASIAVACCINES AND IMMUNIZATIONS65905CHECK / WIRE
SOUTH ASIAVACCINES AND IMMUNIZATIONS179496CHECK / WIRE
SOUTH ASIAVACCINES AND IMMUNIZATIONS580974CHECK / WIRE
SOUTH ASIAVACCINES AND IMMUNIZATIONS143256CHECK / WIRE
SOUTH ASIAVACCINES AND IMMUNIZATIONS66339CHECK / WIRE
SOUTH ASIAVACCINES AND IMMUNIZATIONS94057CHECK / WIRE
SOUTH ASIAVACCINES AND IMMUNIZATIONS449130CHECK / WIRE
SOUTH ASIAVACCINES AND IMMUNIZATIONS53896CHECK / WIRE
SUB-SAHARAN AFRICAVACCINES AND IMMUNIZATIONS125494CHECK / WIRE
SUB-SAHARAN AFRICAVACCINES AND IMMUNIZATIONS241484CHECK / WIRE
SUB-SAHARAN AFRICAVACCINES AND IMMUNIZATIONS1889073CHECK / WIRE
FieldValueIRS element (for citing)
Total Number Of501c3 Orgs23TotalNumberOf501c3Orgs
Total Number Of Other Orgs12TotalNumberOfOtherOrgs
Transfer To Foreign Corp0TransferToForeignCorp
Interest In Foreign Trust0InterestInForeignTrust
Own Foreign Corp0OwnForeignCorp
Passive Foreign Invest Co0PassiveForeignInvestCo
Foreign Partnership0ForeignPartnership
Boycott Countries0BoycottCountries

Form990 Schedule F Part V Form990ScheduleFPartV

FieldValueIRS element (for citing)
IdentifierPROCEDURE FOR MONITORING GRANTS OUTSIDE THE U.S.:Identifier
ExplanationSCHEDULE F, PART I, LINE 2: SUBRECIPIENTS ARE REQUIRED TO SUBMIT PROGRESS REPORTS, WHICH ARE REVIEWED BY RESPONSIBLE PROGRAM MANAGERS AND PROGRAM ADMINISTRATORS TO ENSURE THAT PROGRAM GOALS ARE ATTAINED IN ACCORDANCE WITH AGREEMENT REQUIREMENTS. THE RESPONSIBLE PROGRAM MANAGERS AND PROGRAM ADMINISTRATORS CONTACT SUBRECIPIENTS WITH QUESTIONS AND FOLLOW UP ON ANY CONCERNS. IN SOME CASES, SUBAWARD TERMS MAY REQUIRE SPECIFIED DELIVERABLES IN ADDITION TO, OR IN LIEU OF, TECHNICAL REPORTS. IN ADDITION, DISCRETIONARY ON-SITE VISITS ARE CONDUCTED TO EVALUATE BOTH COMPLIANCE WITH THE SCIENTIFIC OBJECTIVES OF THE PROJECT AND THE APPROPRIATENESS OF THE SUBRECIPIENT'S ADMINISTRATIVE SYSTEMS AND PROCESSES.Explanation

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Records Maintained1RecordsMaintained

Recipient Table RecipientTable (34 entries)

Address Line1AddressUS/AddressLine1CityAddressUS/CityStateAddressUS/StateZIP CodeAddressUS/ZIPCodeEIN Of RecipientEINOfRecipientIRC SectionIRCSectionAmount Of Cash GrantAmountOfCashGrantPurpose Of GrantPurposeOfGrantAddress Line2AddressUS/AddressLine2
UNIVERSITY OF WASHINGTON
4333 BROOKLYN AVE NE BOX 359472SEATTLEWA98195916001537501(C)(3)15823VACCINES AND IMMUNIZATIONS
BROOKHAVEN SCIENCE ASSOCIATES LLC
BROOKHAVEN NATIONAL LABORATORY BLDGUPTONNY119735000113403915N/A6000VACCINES AND IMMUNIZATIONS490-C P O BOX 5000
TUFTS UNIVERSITY
136 HARRISON AVENUEBOSTONMA02111042103634501(C)(3)140000VACCINES AND IMMUNIZATIONS
JOHNS HOPKINS UNIVERSITY
BLOOMBERG SCHOOL OF PUBLIC HEALTHBALTIMOREMD21205520595110501(C)(3)119752VACCINES AND IMMUNIZATIONS615 N WOLFE STREET
WALTER REED ARMY INSTITUTE OF RESEARCH (WRAIR)
503 ROBERT GRANT AVENUESILVER SPRINGMD109107500520664528GOVERNMENT80000VACCINES AND IMMUNIZATIONS
PS3 CORPORATION
13750 SAN PEDRO AVENUE SUITE 640SAN ANTONIOTX78232202159069N/A88726VACCINES AND IMMUNIZATIONS
TULANE EDUCATIONAL FUND
1430 TULANE AVENUE TB-32NEW ORLEANSLA701122632720423889N/A8000VACCINES AND IMMUNIZATIONS
NAT INS OF ALLERGY & INFECTIOUS DISEASE (NIAID)
6610 ROCKLEDGE DRIVE SUITE 2800 MSCBETHESDAMD208926606520858115GOVERNMENT126000VACCINES AND IMMUNIZATIONS6606
LIQUIDIA TECHNOLOGIES INC
419 DAVIS DRIVE SUITE 100DURHAMNC27713201926605N/A1496938VACCINES AND IMMUNIZATIONS
JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH
OFFICE OF RESEARCH ADMINISTRATIONBALTIMOREMD21205520595110501(C)(3)162829VACCINES AND IMMUNIZATIONS615 N WOLFE STREET W1100
CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUECINCINNATIOH45229310833936501(C)(3)46886VACCINES AND IMMUNIZATIONS
INFECTIOUS DISEASE RESEARCH INSTITUTE
1124 COLUMBIA STREET SUITE 400SEATTLEWA98104911608978501(C)(3)44181VACCINES AND IMMUNIZATIONS
GENOCEA BIOSCIENCES INC
161 FIRST STREETCAMBRIDGEMA02139510596811N/A432126VACCINES AND IMMUNIZATIONS
JOHNS HOPKINS UNIVERSITY
BLOOMBERG SCHOOL OF PUBLIC HEALTHBALTIMOREMD21205520595110501(C)(3)28055VACCINES AND IMMUNIZATIONS615 N WOLFE STREET
EMORY UNIVERSITY
1599 CLIFTON RD NE 4TH FLOORATLANTAGA303224250580566256501(C)(3)170670VACCINES AND IMMUNIZATIONSMAILSTOP 1499/001/1BH
WALTER REED ARMY INSTITUTE OF RESEARCH (WRAIR)
503 ROBERT GRANT AVENUESILVER SPRINGMD109107500520664528GOVERNMENT458063VACCINES AND IMMUNIZATIONS
JOHNS HOPKINS UNIVERSITY
BLOOMBERG SCHOOL OF PUBLIC HEALTHBALTIMOREMD21205520595110501(C)(3)600000VACCINES AND IMMUNIZATIONS615 N WOLFE STREET
UNIVERSITY OF ALABAMA
701 20TH STREET SOUTH AB 1170BIRMINGHAMAL352940111636005396501(C)(3)83685VACCINES AND IMMUNIZATIONS
TULANE UNIVERSITY
TULANE SCHOOL OF PUBLIC HEALTH 1440NEW ORLEANSLA70112720423889501(C)(3)49660VACCINES AND IMMUNIZATIONSCANAL ST SUITE 2200
LENTIGEN CORPORATION
910 CLOPPER ROAD SUITE 200GAITHERSBURGMD20878861131845N/A400000VACCINES AND IMMUNIZATIONS
FOOD & DRUG ADMINISTRATION (FDA)
10903 NEW HAMPSHIRE AVENUESILVER SPRINGMD20993530196965GOVERNMENT50000VACCINES AND IMMUNIZATIONS
PURDUE UNIVERSITY
610 PURDUE MALLWEST LAFAYETTEIN479072040356002041501(C)(3)10848VACCINES AND IMMUNIZATIONS
LELAND STANFORD JUNIOR UNIVERSITY
340 PANAMA STSTANFORDCA943056203941156365501(C)(3)26930VACCINES AND IMMUNIZATIONS
WALTER REED ARMY INSTITUTE OF RESEARCH (WRAIR)
503 ROBERT GRANT AVENUESILVER SPRINGMD109107500520664528GOVERNMENT523357VACCINES AND IMMUNIZATIONS
INFECTIOUS DISEASE RESEARCH INSTITUTE
1124 COLUMBIA STREET SUITE 400SEATTLEWA98104911608978501(C)(3)450000VACCINES AND IMMUNIZATIONS
WALTER REED ARMY INSTITUTE OF RESEARCH (WRAIR)
503 ROBERT GRANT AVENUESILVER SPRINGMD109107500520664528GOVERNMENT96250VACCINES AND IMMUNIZATIONS
UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER
1000 SL YOUNGOKLAHOMA CITYOK73104736017987501(C)(3)169322VACCINES AND IMMUNIZATIONS
BLAIR AND COMPANY LLC
602 WEST LYON FARM DRIVEGREENWICHCT06831061515285N/A10788VACCINES AND IMMUNIZATIONS
UNIVERSITY OF PITTSBURGH
OFFICE OF RESEARCH 123 UNIVERSITYPITTSBURGHPA15213250965591501(C)(3)475000VACCINES AND IMMUNIZATIONSPLACE LOWER LOBBY
JOHNS HOPKINS UNIVERSITY
615 N WOLFE STREETBALTIMOREMD21205520595110501(C)(3)1109651VACCINES AND IMMUNIZATIONS
WALTER REED ARMY INSTITUTE OF RESEARCH (WRAIR)
503 ROBERT GRANT AVENUESILVER SPRINGMD109107500520664528GOVERNMENT122350VACCINES AND IMMUNIZATIONS
CHILDREN'S HOSPITAL BOSTON
300 LONGWOOD AVENUEBOSTONMA02115042774441501(C)(3)198310VACCINES AND IMMUNIZATIONS
ST JUDE CHILDREN'S RESEARCH
262 DANNY THOMAS PLACEMEMPHISTN38105620646012501(C)(3)156840VACCINES AND IMMUNIZATIONS
PROGRAM FOR APPROPRIATE TECHNOLOGY IN HEALTH
2201 WESTLAKE AVENUE STE 200SEATTLEWA98121911157127501(C)(3)11312403VACCINES AND IMMUNIZATIONS
FieldValueIRS element (for citing)
Total Nbr Of501 C3 And Govt Grants27TotalNbrOf501C3AndGovtGrants
Total Nbr Of Other Organizations7TotalNbrOfOtherOrganizations

Form990 Schedule I Part IV Form990ScheduleIPartIV

FieldValueIRS element (for citing)
IdentifierPROCEDURE FOR MONITORING GRANTS IN THE U.S.:Identifier
Return ReferencePART I, LINE 2:ReturnReference
ExplanationSCHEDULE I, PART I, LINE 2: SUBRECIPIENTS ARE REQUIRED TO SUBMIT PROGRESS REPORTS, WHICH ARE REVIEWED BY RESPONSIBLE PROGRAM MANAGERS AND PROGRAM ADMINISTRATORS TO ENSURE THAT PROGRAM GOALS ARE ATTAINED IN ACCORDANCE WITH AGREEMENT REQUIREMENTS. THE RESPONSIBLE PROGRAM MANAGERS AND PROGRAM ADMINISTRATORS CONTACT SUBRECIPIENTS WITH QUESTIONS AND FOLLOW UP ON ANY CONCERNS. IN SOME CASES, SUBAWARD TERMS MAY REQUIRE SPECIFIED DELIVERABLES IN ADDITION TO, OR IN LIEU OF, TECHNICAL REPORTS. IN ADDITION, DISCRETIONARY ON-SITE VISITS ARE CONDUCTED TO EVALUATE BOTH COMPLIANCE WITH THE SCIENTIFIC OBJECTIVES OF THE PROJECT AND THE APPROPRIATENESS OF THE SUBRECIPIENT'S ADMINISTRATIVE SYSTEMS AND PROCESSES.Explanation

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Severance Payment0SeverancePayment
Supplemental Nonqual Retire Plan0SupplementalNonqualRetirePlan
Equity Based Comp Arrangement0EquityBasedCompArrangement
Comp Based On Revenue Of Filing Org0CompBasedOnRevenueOfFilingOrg
Comp Based On Revenue Related Orgs0CompBasedOnRevenueRelatedOrgs
Comp Based Net Earnings Filing Org0CompBasedNetEarningsFilingOrg
Comp Based Net Earnings Relate Orgs0CompBasedNetEarningsRelateOrgs
Any Non Fixed Payments0AnyNonFixedPayments
Initial Contract Exception0InitialContractException

Form990 Schedule J Part II Form990ScheduleJPartII (5 entries)

Base Compensation Filing OrgBaseCompensationFilingOrgComp Based On Related OrgsCompBasedOnRelatedOrgsBonus Filing OrgBonusFilingOrgBonus Related OrgsBonusRelatedOrgsOther Compensation Filing OrgOtherCompensationFilingOrgOther Compensation Related OrgsOtherCompensationRelatedOrgsDeferred Comp Filing OrgDeferredCompFilingOrgDeferred Comp Related OrgsDeferredCompRelatedOrgsNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgNontaxable Benefits Related OrgsNontaxableBenefitsRelatedOrgsTotal Compensation Filing OrgTotalCompensationFilingOrgTotal Compensation Related OrgsTotalCompensationRelatedOrgsComp Report Prior990 Filing OrgCompReportPrior990FilingOrgComp Report Prior990 Related OrgsCompReportPrior990RelatedOrgs
CHRISTOPHER J ELIAS
041017101140740200028828010668056394100
JACQUELINE D SHERRIS
024402400030001771101391026342600
ERIC G WALKER
0234966000370024546010618027050000
DAN LASTER
02169270000016666010568024416100
DAVID ALLI
0143147000001717708584016890800

Form990 Schedule J Part III Form990ScheduleJPartIII

FieldValueIRS element (for citing)
Return ReferencePART I, LINE 3ReturnReference
ExplanationPVS RELIES ON A RELATED ORGANIZATION, PATH, TO DETERMINE COMPENSATION. PATH USES THE FOLLOWING METHODS TO ESTABLISH COMPENSATION: - COMPENSATION COMMITTEE - INDEPENDENT COMPENSATION CONSULTANT - WRITTEN EMPLOYMENT CONTRACT - COMPENSATION SURVEY OR STUDY - APPROVAL BY THE BOARD OR COMPENSATION COMMITTEEExplanation

Schedule O IRS990ScheduleO

General Explanation GeneralExplanation (5 entries)

Return ReferenceReturnReferenceExplanationExplanationIdentifierIdentifier
FORM 990, PART VI, SECTION B, LINE 11THE FORM 990 WAS PREPARED BY THE OUTSIDE ACCOUNTING FIRM USING INFORMATION PROVIDED BY PATH ACCOUNTING SERVICES STAFF. PATH SENIOR MANAGEMENT REVIEWED THE DRAFT FORM. A COPY OF THE FINAL 990 WAS SENT TO THE BOARD OF DIRECTORS FOR COMMENT. AFTER THE COMMENT PERIOD, THE PRESIDENT AND CEO SIGNED THE RETURN.
FORM 990, PART VI, SECTION B, LINE 12CBOARD MEMBERS, PVS MANAGEMENT, AND ALL STAFF ABOVE A DESIGNATED LEVEL MUST COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM EACH YEAR. ALL FORMS ARE REVIEWED AND KEPT ON FILE. A CONFLICT MANAGEMENT PLAN IS DEVELOPED FOR ANY EMPLOYEE WITH A SIGNIFICANT ACTUAL OR PERCEIVED CONFLICT OF INTEREST. EACH YEAR AT THE ANNUAL MEETING, THE GENERAL COUNSEL INFORMS BOARD MEMBERS OF THE REQUIREMENT TO DISCLOSE ANY CONFLICT OF INTEREST. EACH BOARD MEMBER COMPLETES AND SIGNS A CONFLICT FORM ANNUALLY.
FORM 990, PART VI, SECTION C, LINE 19PVS'S FINANCIAL STATEMENTS, GOVERNING DOCUMENTS, AND CONFLICT OF INTEREST POLICY ARE MADE AVAILABLE UPON REQUEST.
FORM 990, PART XI, LINE 5:NET UNREALIZED LOSSES ON INVESTMENTS: -459,773.CHANGES IN NET ASSETS OR FUND BALANCES:
FORM 990, PART VII, SECTION A, COLUMN (B):CHRISTOPHER J. ELIAS, CHAIR, DEVOTED 40 HOURS PER WEEK TO THE PROGRAM FOR APPROPRIATE TECHNOLOGY IN HEALTH (PATH), AS ITS PRESIDENT AND CEO. JACQUELINE D. SHERRIS, VICE CHAIR, DEVOTED 40 HOURS PER WEEK TO PATH AS ITS VICE PRESIDENT OF GLOBAL PROGRAMS. ERIC G. WALKER, TREASURER, DEVOTED 40 HOURS PER WEEK TO PATH AS ITS VICE PRESIDENT OF CORPORATE SERVICES. DAN LASTER, DIRECTOR, DEVOTED 40 HOURS PER WEEK TO PATH AS ITS GENERAL COUNSEL. DAVID ALLI, BOARD SECRETARY, DEVOTED 40 HOURS PER WEEK TO PATH AS ITS DIRECTOR OF ADMINISTRATION AND FINANCE FOR VACCINE DEVELOPMENT.

Schedule R IRS990ScheduleR

Form990 Schedule R Part II Form990ScheduleRPartII

Name Of Disregarded Entity NameOfDisregardedEntity

FieldValueIRS element (for citing)
Business Name Line1PROGRAM FOR APPROPRIATE TECHNOLOGY IN HEALTHBusinessNameLine1

Address US AddressUS

FieldValueIRS element (for citing)
Address Line12201 WESTLAKE AVE SUITE 200AddressLine1
CitySEATTLECity
StateWAState
ZIP Code98109ZIPCode
FieldValueIRS element (for citing)
EIN911157127EIN
Primary ActivitiesGLOBAL HEALTHPrimaryActivities
Legal Domicile StateWALegalDomicileState
Exempt Code Section501(C)(3)ExemptCodeSection
Public Charity StatusBOX 7PublicCharityStatus
Direct Controlling Entity NAN/ADirectControllingEntityNA
Controlled Org0ControlledOrg
FieldValueIRS element (for citing)
Receipt Of Int Ann Rents Royalties0ReceiptOfIntAnnRentsRoyalties
Gift Grant Or Cap Contr To Other Org1GiftGrantOrCapContrToOtherOrg
Gift Grant Or Cap Contr Fr Other Org0GiftGrantOrCapContrFrOtherOrg
Loans Or Guarantees To Other Org0LoansOrGuaranteesToOtherOrg
Loans Or Guarantees From Other Org0LoansOrGuaranteesFromOtherOrg
Sale Of Assets To Other Org0SaleOfAssetsToOtherOrg
Purchase Of Assets From Other Org0PurchaseOfAssetsFromOtherOrg
Exchange Of Assets0ExchangeOfAssets
Rental Of Facilities To Other Orgs0RentalOfFacilitiesToOtherOrgs
Rental Of Facilities Fr Other Orgs0RentalOfFacilitiesFrOtherOrgs
Perform Of Services For Other Orgs0PerformOfServicesForOtherOrgs
Perform Of Services By Other Orgs0PerformOfServicesByOtherOrgs
Sharing Of Facilities0SharingOfFacilities
Sharing Of Paid Employees0SharingOfPaidEmployees
Reimbursement Paid To Other Org1ReimbursementPaidToOtherOrg
Reimbursement Paid By Other Org0ReimbursementPaidByOtherOrg
Other Transfer To Other Org0OtherTransferToOtherOrg
Other Transfer From Other Org0OtherTransferFromOtherOrg

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.